Upload
PPT-Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory

PPT-Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory

Author : skylar | Published Date : 2023-07-26

Meltzer MI Multiple Contact Dates and SARS Incubation Periods Emerg Infect Dis 2004102207209 httpsdoiorg103201eid1002030426

data periods incubation figure periods data multiple period

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 2 Figure 2. . . Cumulative freque..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory: Transcript

Meltzer MI Multiple Contact Dates and SARS Incubation Periods Emerg Infect Dis 2004102207209 httpsdoiorg103201eid1002030426. By: Yazmin Realivasquez. Stephen Huang . Jose Torres. What is ARDS?. ARDS is a respiratory condition characterized by hypoxemia, and stiff lungs, without mechanical ventilation most patients would die. ARDS represents a response to many different insults/injuries and evolves through different phases: alveolar capillary damage to lung resolution to a fibro-proliferative phase. The pulmonary epithelial and endothelial cellular damage is characterized by inflammation, apoptosis, necrosis and increased alveolar-capillary permeability, which lead to the development of alveolar edema. . Loutfy MR, Wallington T, Rutledge T, Mederski B, Rose K, Kwolek S, et al. Hospital Preparedness and SARS. Emerg Infect Dis. 2004;10(5):771-776. https://doi.org/10.3201/eid1005.030717. Assiri AM, Abedi GR, Saeed AA, Abdalla MA, al-Masry M, Choudhry A, et al. Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia. Emerg Infect Dis. 2016;22(1):32-40. https://doi.org/10.3201/eid2201.151370. Goldsmith CS, Tatti KM, Ksiazek TG, Rollin PE, Comer JA, Lee WW, et al. Ultrastructural Characterization of SARS Coronavirus. Emerg Infect Dis. 2004;10(2):320-326. https://doi.org/10.3201/eid1002.030913. Meltzer MI. Estimating SARS Incubation Period. Emerg Infect Dis. 2004;10(8):1504. https://doi.org/10.3201/eid1008.040427. Chan PK, Ip M, Ng K, Chan RC, Wu A, Lee N, et al. Severe Acute Respiratory Syndrome–associated Coronavirus Infection. Emerg Infect Dis. 2003;9(11):1453-1454. https://doi.org/10.3201/eid0911.030421. Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg Infect Dis. 2020;26(6):1266-1273. https://doi.org/10.3201/eid2606.200516. Angelakis E, Patrick G, Peloni J, Wey P, Perreal C, Raoult D. Orientia tsutsugamushi in Lung of Patient with Acute Respiratory Distress Syndrome, France, 2013. Emerg Infect Dis. 2015;21(2):373-375. https://doi.org/10.3201/eid2102.140860. Guo Z, Wang Z, Zhang S, Li X, Li L, Li C, et al. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerg Infect Dis. 2020;26(7):1583-1591. https://doi.org/10.3201/eid2607.200885. Kaydos-Daniels SC, Olowokure B, Chang H, Barwick RS, Deng J, Lee M, et al. Body Temperature Monitoring and SARS Fever Hotline, Taiwan. Emerg Infect Dis. 2004;10(2):373-376. https://doi.org/10.3201/eid1002.030748. Freuling CM, Breithaupt A, Müller T, Sehl J, Balkema-Buschmann A, Rissmann M, et al. Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection. Emerg Infect Dis. 2020;26(12):2982-2985. https://doi.org/10.3201/eid2612.203733. Goldsmith CS, Ksiazek TG, Rollin PE, Comer JA, Nicholson WL, Peret T, et al. Cell Culture and Electron Microscopy for Identifying Viruses in Diseases of Unknown Cause. Emerg Infect Dis. 2013;19(6):886-891. https://doi.org/10.3201/eid1906.130173. Kratzel A, Todt D, V’kovski P, Steiner S, Gultom M, Thao T, et al. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols. Emerg Infect Dis. 2020;26(7):1592-1595. https://doi.org/10.3201/eid2607.200915. Martines RB, Ritter JM, Matkovic E, Gary J, Bollweg BC, Bullock H, et al. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States. Emerg Infect Dis. 2020;26(9):2005-2015. https://doi.org/10.3201/eid2609.202095.

Download Document

Here is the link to download the presentation.
"Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Figure 2 Figure 2. Standardized follow-up checklist of patients with severe acute

Figure 2 Figure 2. Standardized follow-up checklist of patients with severe acute
Figure 1 Figure 1. Middle East respiratory syndrome coronavirus (MERS-CoV) case-patients

Figure 1 Figure 1. Middle East respiratory syndrome coronavirus (MERS-CoV) case-patients
Figure 1 Figure 1. Assembly of severe acute respiratory syndrome–associated

Figure 1 Figure 1. Assembly of severe acute respiratory syndrome–associated
Figure 1 Figure 1. Simulation of frequency distribution of incubation period

Figure 1 Figure 1. Simulation of frequency distribution of incubation period
Figure Figure. Number of patients with severe acute respiratory syndrome (SARS)

Figure Figure. Number of patients with severe acute respiratory syndrome (SARS)
Figure 1 Figure 1. Cytopathic effect caused by severe acute respiratory syndrome coronavirus

Figure 1 Figure 1. Cytopathic effect caused by severe acute respiratory syndrome coronavirus
Figure Figure. Orientia tsutsugamushi (arrows) in culture of bronchoalveolar lavage fluid

Figure Figure. Orientia tsutsugamushi (arrows) in culture of bronchoalveolar lavage fluid
Figure 2 Figure 2. Spatial distribution of severe acute respiratory syndrome coronavirus

Figure 2 Figure 2. Spatial distribution of severe acute respiratory syndrome coronavirus
Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome

Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome
Figure 2 Figure 2. Detection of severe acute respiratory syndrome coronavirus 2 in swab

Figure 2 Figure 2. Detection of severe acute respiratory syndrome coronavirus 2 in swab
Figure 1 Figure 1. . . A) Cell culture isolate of severe acute respiratory syndrome coronavirus,

Figure 1 Figure 1. . . A) Cell culture isolate of severe acute respiratory syndrome coronavirus,
Figure 2 Figure 2. Effect of commercially available alcohols in inactivating SARS-CoV-2.

Figure 2 Figure 2. Effect of commercially available alcohols in inactivating SARS-CoV-2.
Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in

Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in